Both Nonsmoking Youth and Smoking adults Like Sweet and Minty E-liquid Flavors More Than Tobacco Flavor.
Population Clinical
Consumer Use
Flavor Appeal
Krüsemann (2021)
Elemental analysis of Tetrahydrocannabinol and Nicotine E-Liquids Related to EVaLI.
Nonclinical
Chemical
Analysis
Kubachka (2021)
Determination of Glycerol, Propylene Glycol, and Nicotine as the Main Components in Refill Liquids for Electronic Cigarettes.
Nonclinical
Chemical
Analysis
Kubica (2023)
Composition of aerosols from thermal degradation of flavors used in ENDS and tobacco products.
Nonclinical
Chemical
Analysis
Kuehl (2022)
Comparative inhalation exposure/toxicology analysis of e-cigarette vapors with different puffing behaviors using PBPK-CSP-CFD approach.
Nonclinical
ALL
In Vitro
Kuga (2019)
age, gender and socioeconomic patterns of awareness and usage of e-cigarettes across selected WhO region countries: evidence from the Global adult Tobacco Survey.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Kundu (2023)
acrolein, e-cigarettes, and pulmonary and vascular damage.
Individual Clinical
Safety
Adverse Effects
Kuntic (2020)
Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NaDPh oxidase (NOX-2).
Nonclinical
Cardiovascular Toxicity
In Vivo
Kuntic (2020)
The role of acrolein for E-cigarette vapour condensate mediated activation of NaDPh oxidase in cultured endothelial cells and macrophages.
Nonclinical
Cardiovascular Toxicity
In Vivo
Kuntic (2023)
Impact of electronic nicotine delivery systems and other respondent characteristics on tobacco use transitions among a U.S. national sample of women of reproductive age.
Population Clinical
Likelihood Of Use
Kurti (2020)